Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 06, 2025 17:30 ET | Source: Fulcrum Therapeutics, Inc. ― Clear…
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinsons Disease
December 05, 2025 21:00 ET | Source: Cerevance, Inc. Phase 2 results…
MapLight Therapeutics Reports Third Quarter Financial Results and Highlights Corporate Progress
Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected…
Cango Inc. Reports Third Quarter 2025 Unaudited Financial Results
DALLAS, Dec. 2, 2025 /PRNewswire/ -- On December 1, Cango Inc. (NYSE:…
Kia Announces November 2025 Global Sales Results
November 2025 global sales of 262,065 units, down 0.8% Y/yIn Korea, Kia…
Acceleware Ltd. Reports Third Quarter 2025 Financial and Operating Results
CALGARY, Alberta, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or…
HP Inc. Reports Fiscal 2025 Full Year and Fourth Quarter Results
PALO ALTO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ)…
DLH to Announce Fiscal 2025 Fourth Quarter Financial Results
November 20, 2025 13:37 ET | Source: DLH Holdings Corp. ATLANTA, Nov.…
Euro NCAP announces test results for 23 new cars
LEUVEN, BELGIUM – The scores are in on Euro NCAP's biggest group…
Range Impact Reports 3Q 2025 Financial Results
Cleveland, Ohio, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB:…
